再鼎医药下跌2.23%,报27.19美元/股

金融界
08 Feb

2月8日,再鼎医药(ZLAB)盘中下跌2.23%,截至00:17,报27.19美元/股,成交195.54万美元。

财务数据显示,截至2024年09月30日,再鼎医药收入总额2.9亿美元,同比增长44.32%;归母净利润-1.75亿美元,同比增长26.66%。

大事提醒:

2月27日,再鼎医药将于(美东)盘前披露2024财年年报(数据来源于纳斯达克官网,预计披露日期为美国当地时间,实际披露日期以公司公告为准)。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10